In the last 12 months, insiders at Black Diamond Therapeutics, Inc. ($BDTX) filed 64 transactions with the SEC: 0 open-market purchases totaling $0 and 8 sales totaling $13,398,305. Net insider sentiment: net selling.
Black Diamond Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- BIOTECH GROWTH N V (TenPercentOwner) — 7 transactions totaling $11,997,749
- Versant Venture Capital VI, L.P. (Not found) — 1 transaction totaling $1,400,556
- Behbahani Ali (Not found) — 11 transactions totaling $129,875
- Raman Prakash (Not found) — 11 transactions totaling $101,836
- Campbell Shannon (Not found) — 6 transactions totaling $32,517
View all SEC Filings for Black Diamond Therapeutics, Inc. (BDTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Behbahani Ali | Not found | A | Common Stock | 6919 | $2.15 | 4,542,325.0000 | 57,480,512 | 0.15% | 0.01% |
| March 20, 2026 | Raman Prakash | Not found | A | Common Stock | 6105 | $2.15 | 37,132.0000 | 57,480,512 | 19.68% | 0.01% |
| Jan. 21, 2026 | Hatzis-Schoch Brent | SEE REMARKS | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 57,480,512 | 9999.99% | 0.43% |
| Jan. 21, 2026 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 57,480,512 | 9999.99% | 0.43% |
| Jan. 21, 2026 | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 57,480,512 | 9999.99% | 1.04% |
| Jan. 21, 2026 | Jones Erika | SEE REMARKS | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 57,480,512 | 9999.99% | 0.35% |
| Jan. 21, 2026 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 57,480,512 | 9999.99% | 0.43% |
| Dec. 12, 2025 | Raman Prakash | Not found | A | Common Stock | 4665 | $2.76 | 31,027.0000 | 57,480,512 | 17.70% | 0.01% |
| Dec. 12, 2025 | Behbahani Ali | Not found | A | Common Stock | 5208 | $2.76 | 4,535,406.0000 | 57,480,512 | 0.11% | 0.01% |
| Sept. 19, 2025 | Behbahani Ali | Not found | A | Common Stock | 4291 | $3.35 | 4,530,198.0000 | 55,028,371 | 0.09% | 0.01% |
| Sept. 19, 2025 | Raman Prakash | Not found | A | Common Stock | 3843 | $3.35 | 26,362.0000 | 55,028,371 | 17.07% | 0.01% |
| June 20, 2025 | Behbahani Ali | Not found | A | Common Stock | 6170 | $2.33 | 4,525,907.0000 | 55,028,371 | 0.14% | 0.01% |
| June 20, 2025 | Raman Prakash | Not found | A | Common Stock | 5526 | $2.33 | 22,519.0000 | 55,028,371 | 32.52% | 0.01% |
| June 12, 2025 | Dhingra Kapil | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 12, 2025 | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 12, 2025 | Raman Prakash | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 12, 2025 | Menzel Garry E | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 12, 2025 | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 12, 2025 | Kulkarni Samarth | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| March 21, 2025 | Behbahani Ali | Not found | A | Common Stock | 7646 | $1.88 | 4,519,737.0000 | 55,028,371 | 0.17% | 0.01% |
| March 21, 2025 | Raman Prakash | Not found | A | Common Stock | 6848 | $1.88 | 16,993.0000 | 55,028,371 | 67.50% | 0.01% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 300000 | $1.94 | 7,217,839.0000 | 55,028,371 | 3.99% | 0.55% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 1000000 | $2.31 | 6,217,839.0000 | 55,028,371 | 13.85% | 1.82% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 2000000 | $2.00 | 4,217,839.0000 | 55,028,371 | 32.17% | 3.63% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 400000 | $2.09 | 3,817,839.0000 | 55,028,371 | 9.48% | 0.73% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 584292 | $1.95 | 3,233,547.0000 | 55,028,371 | 15.30% | 1.06% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 500000 | $2.12 | 2,733,547.0000 | 55,028,371 | 15.46% | 0.91% |
| March 19, 2025 | BIOTECH GROWTH N V | TenPercentOwner | S | Common Stock | 1000000 | $2.07 | 7,517,839.0000 | 55,028,371 | 11.74% | 1.82% |
| Jan. 30, 2025 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 75000 | $0.00 | 170,192.0000 | 55,028,371 | 78.79% | 0.14% |
| Jan. 30, 2025 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 55,028,371 | 9999.99% | 0.32% |
| Jan. 30, 2025 | Jones Erika | SEE REMARKS | A | Common Stock | 75000 | $0.00 | 85,150.0000 | 55,028,371 | 738.92% | 0.14% |
| Jan. 30, 2025 | Jones Erika | SEE REMARKS | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 55,028,371 | 9999.99% | 0.23% |
| Jan. 30, 2025 | Hatzis-Schoch Brent | SEE REMARKS | A | Common Stock | 75000 | $0.00 | 83,400.0000 | 55,028,371 | 892.86% | 0.14% |
| Jan. 30, 2025 | Hatzis-Schoch Brent | SEE REMARKS | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 55,028,371 | 9999.99% | 0.32% |
| Jan. 30, 2025 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 55,028,371 | 9999.99% | 0.36% |
| Jan. 30, 2025 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 55,028,371 | 9999.99% | 0.14% |
| Jan. 30, 2025 | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 55,028,371 | 9999.99% | 0.91% |
| Jan. 30, 2025 | Velleca Mark A. | PRESIDENT & CEO | A | Common Stock | 75000 | $0.00 | 121,522.0000 | 55,028,371 | 161.21% | 0.14% |
| Dec. 13, 2024 | Behbahani Ali | Not found | A | Common Stock | 5750 | $2.50 | 4,512,091.0000 | 56,507,956 | 0.13% | 0.01% |
| Dec. 13, 2024 | Raman Prakash | Not found | A | Common Stock | 5150 | $2.50 | 10,145.0000 | 56,507,956 | 103.10% | 0.01% |
| Dec. 13, 2024 | Campbell Shannon | Not found | A | Common Stock | 4500 | $2.50 | 8,865.0000 | 56,507,956 | 103.09% | 0.01% |
| Sept. 20, 2024 | Campbell Shannon | Not found | A | Common Stock | 2354 | $4.78 | 4,365.0000 | 43,954,649 | 117.06% | 0.01% |
| Sept. 20, 2024 | Behbahani Ali | Not found | A | Common Stock | 3007 | $4.78 | 4,506,341.0000 | 43,954,649 | 0.07% | 0.01% |
| Sept. 20, 2024 | Raman Prakash | Not found | A | Common Stock | 2694 | $4.78 | 4,995.0000 | 43,954,649 | 117.08% | 0.01% |
| Aug. 28, 2024 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 221600 | $6.32 | 6,206,964.0000 | 43,954,649 | 3.45% | 0.50% |
| June 21, 2024 | Behbahani Ali | Not found | A | Common Stock | 2887 | $4.98 | 4,503,334.0000 | 43,954,649 | 0.06% | 0.01% |
| June 21, 2024 | Raman Prakash | Not found | A | Common Stock | 2301 | $4.98 | 2,301.0000 | 43,954,649 | 9999.99% | 0.01% |
| June 21, 2024 | Campbell Shannon | Not found | A | Common Stock | 2011 | $4.98 | 2,011.0000 | 43,954,649 | 9999.99% | 0.00% |
| June 6, 2024 | Kulkarni Samarth | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| June 6, 2024 | Menzel Garry E | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| June 6, 2024 | Raman Prakash | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| June 6, 2024 | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| June 6, 2024 | Dhingra Kapil | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| June 6, 2024 | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| April 10, 2024 | Raman Prakash | Not found | A | Stock Option (Right to Buy) | 61100 | $0.00 | 61,100.0000 | 43,954,649 | 9999.99% | 0.14% |
| April 10, 2024 | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 61100 | $0.00 | 61,100.0000 | 43,954,649 | 9999.99% | 0.14% |
| March 15, 2024 | Behbahani Ali | Not found | A | Common Stock | 3166 | $4.54 | 4,500,447.0000 | 43,954,649 | 0.07% | 0.01% |
| March 15, 2024 | DIXON WENDY L | Not found | A | Common Stock | 3253 | $4.54 | 38,054.0000 | 43,954,649 | 9.35% | 0.01% |
| Feb. 14, 2024 | Ni Fang | SEE REMARKS | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 43,954,649 | 9999.99% | 0.46% |
| Feb. 14, 2024 | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 537000 | $0.00 | 537,000.0000 | 43,954,649 | 9999.99% | 1.22% |
| Feb. 14, 2024 | Jones Erika | SEE REMARKS | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 43,954,649 | 9999.99% | 0.23% |
| Feb. 14, 2024 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 43,954,649 | 9999.99% | 0.46% |
| Feb. 14, 2024 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 43,954,649 | 9999.99% | 0.51% |
| Feb. 14, 2024 | Hatzis-Schoch Brent | SEE REMARKS | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 43,954,649 | 9999.99% | 0.46% |